{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260610278575/en/Genmab-Announces-Epcoritamab-Monotherapy-and-Epcoritamab-Based-Combination-Regimens-Demonstrate-High-Response-Rates-in-Elderly-Patients-with-Newly-Diagnosed-Diffuse-Large-B-Cell-Lymphoma-DLBCL", "message": "News view counter 798409 successfully enlarged"}